Advertisement

Manifestations of Hypersecretion of Adrenal Sex Steroids in Man

  • Patricia Zeis Thomas
Part of the Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology book series (HEP, volume 14 / 3)

Abstract

The adrenal cortex is believed to secrete steroids with androgenic and estrogenic activity or precursors which are transformed to androgenic or estrogenic substances outside the adrenal cortex. Howard and Migeon (1962) in Chapter 5 of Part 1 of this Volume have reviewed the evidence for the secretion of sex hormones by the normal adrenal cortex. Excessive secretion of androgens and estrogens, regardless of origin, results in precocious and exaggerated isosexual or heterosexual physical changes in the organism. This chapter is confined to the consideration of certain clinical syndromes in the human being which are attributed to adrenocortical disease and in which manifestations of feminization or masculinization occur. These manifestations may be isosexual, i.e. feminization of the female and masculinization of the male, or heterosexual, i.e. masculinization of the female and feminization of the male. As will become apparent, abnormalities of the adrenocortical secretion of a quantitative and, possibly, of a qualitative nature may be caused by disease of the adrenal gland itself or may be a secondary consequence of disease of other endocrine glands such as the pituitary or gonads.

Keywords

Adrenal Cortex Congenital Adrenal Hyperplasia Adrenal Tumor Electrolyte Imbalance External Genitalia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature

  1. Ainger, L. E., G. C. Zapata, R. S. Ely, and V. C. Kelley: The occurrence of congenita adrenal hyperplasia in first cousins. Amer. J. Dis. Child. 99, 636–641 (1960).Google Scholar
  2. Albright, F.: Cushing’s syndrome. Its pathological physiology, its relationship to the adreno-genital syndrome, and its connection with the problem of the reaction of the body to injurious agents (“alarm reaction” of Selye). Harvey Lect. 38, 123–186 (1942–1943).Google Scholar
  3. — F., A. P. Forbes, R. Fraser, R. B. Miller, and E. C. Reifenstein, Jr.: A classification of the causes of hypoleydigism. Trans. Ass. Amer. Phycns 56, 43–54 (1941).Google Scholar
  4. Alexander, W. S., and O. D. Beresford: Masculinization of ovarian origin. Report of a case with virilization developing during pregnancy. J. Obstet. Gynaec. Brit. Emp. 60, 252–258 (1953).PubMedCrossRefGoogle Scholar
  5. Avin, J.: Female pseudohermaphroditism with delivery of a normal child. Pediatrics 29, 828–830 (1962).PubMedGoogle Scholar
  6. Axelrod, L. R.: Steroid-producing endocrine organs. Their common origins and metabolic activities. Tex. St. J. Med. 57, 974–977 (1961).Google Scholar
  7. —, L. R., and J. W. Goldzieher: The metabolism of 17 α-hydroxyprogesterone and its relation to congenital adrenal hyperplasia. J. clin. Endocr. 20, 238–252 (1960).PubMedCrossRefGoogle Scholar
  8. Barr, M. L., and E. G. Bertram: A morphological distinction between neurones of the male and female, and the behavior of the nucleolar satellite during accelerated nucleoprotein synthesis. Nature (Lond.) 163, 676–677 (1949).CrossRefGoogle Scholar
  9. — L. F. Bertram, and H. A. Lindsay: The morphology of the nerve cell nucleus, according to sex. Anat. Rec. 107, 283–292 (1950).PubMedCrossRefGoogle Scholar
  10. Bartter, F. C., F. Albright, A. P. Forbes, A. Leaf, E. Dempsey, and E. Carroll: The effect of adrenocorticotrophic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: an attempt to explain and correct its disordered hormonal pattern. J. clin. Invest. 30, 237–250 (1951).PubMedCrossRefGoogle Scholar
  11. — F. C., A. P. Forbes, and A. Leaf: Congenital adrenal hyperplasia associated with the adrenogenital syndrome: an attempt to correct its disordered hormonal pattern. J. clin. Invest. 29, 797 (1950).PubMedCrossRefGoogle Scholar
  12. —, and P. Pronove: Cit. by G. M. Tomkins and J. S. McGuire, The adrenogenital syndrome. In: J. B. Stanbury, J. B. Wyngaarden and D. S. Fredrickson (eds.), The metabolic basis of inherited disease, p. 637–676, New York: McGraw 1960.Google Scholar
  13. Bassöe, H. H., R. Emberland, and K. F. Stöa: Fluctuating steroid excretion in Cushing’s syndrome. Acta endocr. (Kbh.) 28, 163–168 (1958).Google Scholar
  14. Baulieu, É.- É.: Isolement dans le plasma et dans l’urine d’ester-sulfate de 5-androstène-3β ol-17-one chez une malade atteinte de tumeur surrénalienne. C. R. Acad. Sci. (Paris) 248, 1441–1443 (1959).Google Scholar
  15. Baulieu, É.- É.: Esters-sulfates de stéroïdes hormonaux. Isolement de l’ester-sulfate de 5-androstène-3β-ol-17-one (dehydroépiandrostérone) dans tumeur cortico-surrénalienne. Absence du stéroide lïbre. C. R. Acad. Sci. (Paris) 251, 1421–1423 (1960).Google Scholar
  16. — Studies of conjugated 17-ketosteroids in a case of adrenal tumor. J. clin. Endocr. 22, 501–510 (1962).PubMedCrossRefGoogle Scholar
  17. — E. Charollais et M. De Vigan: Étude par chromatagraphie sur papier des stéroïdes corticaux dans deux virilismes d’origine surrénalienne (hyperplasier acquise et congenitale). Ann. Biol. clin. 14, 669–675 (1956).Google Scholar
  18. — R. Emiliozzi et C. Corpechot: Isolement dans le plasma veineux pérephérique et surrénalien de l’ester-sulfate de 5-androsténe-3β ol-7,17-dione. Experientia (Basel) 17, 110–111 (1961).CrossRefGoogle Scholar
  19. — L. G. huis in’t veld, A. Jaoudé et M. F. Jayle: Fractionnement et mesure des 17-cetosteroides urinaires neutres au cours de la maladie de Cushing. Acta endocr. (Kbh.) 26, 153–172 (1957).Google Scholar
  20. Baylis, R. I. S., I. E. Broadbent, and A. W. Steinbeck: Congenital adrenal hyperplasia. Effects of corticotrophin and tetrahydrocortisone. Lancet 1954I, 434–435.Google Scholar
  21. Beas, F., R. P. Zurbrügg, J. Cara, and L.I. Gardner: Urinary C19 steroids in normal children and adults. J. clin. Endocr. 22, 1090–1094 (1962).PubMedCrossRefGoogle Scholar
  22. Benedict, P. H., R. B. Cohen, O. Cope, and R. E. Scully: Ovarian and adrenal morphology in cases of hirsutism or virilism and Stein-Leventhal syndrome. Fertil. and Steril. 13, 380–395 (1962).Google Scholar
  23. Benner, M. C.: Studies on the involution of the fetal cortex of the adrenal glands. Amer. J. Path. 16, 787–798 (1940).PubMedGoogle Scholar
  24. Bentinck, R. C., F. Hinman, Jr., H. Lisser, and H. F. Traut: The familial congenital adrenal syndrome: report of two cases and review of the literature. Postgrad. Med. 11, 301–312 (1952).PubMedGoogle Scholar
  25. Bergman, P., B. Sjögren, and B. Håkansson: Hypertensive form of congenital adrenocortical hyperplasia. Analysis of a case with co-existing polycystic ovaries. Acta endocr. (Kbh.) 40, 555–564 (1962).Google Scholar
  26. Bergstrand, C. G., G. Birke, and L.-O. Plantin: Chromatographic studies of the excretion of ketosteroids in children with the adrenogenital syndrome. Acta paediat. (Uppsala) 44, Suppl. 103, 95 (1955).CrossRefGoogle Scholar
  27. — — — The corticosteroid excretion pattern in infants and children with the adrenogenital syndrome. Acta endocr. (Kbh.) 30, 500–508 (1959).Google Scholar
  28. — — — Differences in corticosteroid excretion pattern between infants and children with the adrenogenital syndrome. Acta endocr. (Kbh.) 34, 508–512 (1960).Google Scholar
  29. Béthoux, R., P. Guinet, J. Perrin, R. Mornex et J.-P. Pedard: Une observation de corticosurrénalome malin avec gynécomastie. II. Étude biochemique. Ann. Endocr. (Paris) 17, 75–82 (1956).Google Scholar
  30. Biancalana, D., e R. Romanelli: Adrenocarcinoma femminilizzante. Folia endocr. (Pisa) 11, 655–688 (1958).Google Scholar
  31. Bierich, J. R., E. Bohe, and Kl.-D. Voigt: New aspects of the pathogenesis of the adrenogenital syndrome. Acta endocr. (Kbh.) 18, 512–520 (1955).Google Scholar
  32. Bigozzi, U., A. Borghi, G. Giusti, F. Morabito, and R. Toccafondi: An unusual case of adrenal dysfunction in the male. J. clin. Endocr. 19, 1506–1510 (1959).PubMedCrossRefGoogle Scholar
  33. Birke, G.: The effect of Reichstein’s substance S on the excretion of 17-ketosteroids. Acta endocr. (Kbh.) 15, 17–24 (1954).Google Scholar
  34. — E. Diczfalusy, L.-O. Plantin, H. Robbe, and A. Westman: Familial congenital hyperplasia of the adrenal cortex. Acta endocr. (Kbh.) 29, 55–69 (1958).Google Scholar
  35. —, and L.-O. Plantin: A steroid metabolic study on adrenalectomized patients after administration of compounds E and F and Reichstein’s substance S. Acta endocr. (Kbh.) 15, 61–65 (1954).Google Scholar
  36. Black, J. A., and J. F. R. Bentley: Effect on the foetus of androgens given during pregnancy. Lancet 1959I, 21–24.CrossRefGoogle Scholar
  37. Blackman, S. S., Jr.: Concerning the function and origin of the reticular zone of the adrenal cortex: hyperplasia in the adrenogenital syndrome. Bull. Johns Hopk. Hosp. 78, 180–217 (1946).Google Scholar
  38. Blehova, B., J. Cizkova-Pisarovicova, J. Hynie, B. Sekla, and L. Starka: Contribution to genetic problem of adrenogenital syndrome. Acta genet. (Basel) 11, 52–57 (1961).Google Scholar
  39. Blizzard, R. M., G. W. Liddle, C. J. Migeon, and L. Wilkins: Aldosterone excretion in virilizing adrenal hyperplasia. J. clin. Invest. 38, 1442–1451 (1959).PubMedCrossRefGoogle Scholar
  40. —, and L. Wilkins: Present concepts of steroid therapy in virilizing adrenal hyperplasia. Arch. intern. Med. 100, 729–738 (1957).CrossRefGoogle Scholar
  41. Bloch, E., and K. Benirschke: Synthesis in vitro of steroids by human fetal adrenal gland slices. J. biol. Chem. 234, 1085–1089 (1959).PubMedGoogle Scholar
  42. Bloch, E., K. Benirschke, and R. I. Dorfman: The presence of Δ 4-androstene 3,17-dione in prenatal and postnatal human adrenal glands. J. clin. Endocr. 15, 379–382 (1955).CrossRefGoogle Scholar
  43. — —, and E. Rosemberg: C19-Steroids, 17α-hydroxycorticosterone and a sodium retaining factor in human fetal adrenal glands. Endocrinology 58, 626–633 (1956a).PubMedCrossRefGoogle Scholar
  44. — R. I. Dorfman, and G. Pincus: The conversion of acetate to dehydroepiandrosterone by human adrenal gland slices. Arch. Biochem. 61, 245–247 (1956b).PubMedCrossRefGoogle Scholar
  45. — — — The conversion of acetate to C19 steroids by human adrenal gland slices. J. biol. Chem. 224, 737–750 (1957).PubMedGoogle Scholar
  46. — E., B. Tissenbaum, B. L. Rubin, and H. W. Deane: Δ 5-3β-Hydroxysteroid dehydrogenase activity in human fetal adrenals. Endocrinology 71, 629–632 (1962).CrossRefGoogle Scholar
  47. Blodgett, F. M., R. H. Berki, and W. L. Herrmann: Hypospadias in a male infant with the adrenogenital syndrome. J. clin. Endocr. 21, 1087–1091 (1961).CrossRefGoogle Scholar
  48. Bondy, P. K., G. L. Cohn, W. Herrmann, and K. R. Crispell: The possible relationship of etiocholanolone to periodic fever. Yale J. Biol. Med. 30, 395–405 (1958).PubMedGoogle Scholar
  49. Bongiovanni, A. M.: Detection of pregnanediol and pregnanetriol in the urine of patients with adrenal hyperplasia. Suppression with cortisone. Bull. Johns Hopk. Hosp. 92, 244–251 (1953).Google Scholar
  50. — In vitro hydroxylation of steroids by whole adrenal homogenates of beef, normal man, and patients with the adrenogenital syndrome. J. clin. Invest. 37, 1342–1347 (1958).PubMedCrossRefGoogle Scholar
  51. — Unusual steroid pattern in congenital adrenal hyperplasia: deficiency of 3β-hydroxy dehydrogenase. J. clin. Endocr. 21, 860–862 (1961).CrossRefGoogle Scholar
  52. — The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase. J. clin. Invest. 41, 2086–2092 (1962).PubMedCrossRefGoogle Scholar
  53. —, and A. Clark: Urinary Δ 5-pregnene-3β,17α,20α,21-tetrol in 3β-ol-dehydrogenase deficiency. J. clin. Invest. 41, 1346 (1962).CrossRefGoogle Scholar
  54. —, and G. W. Clayton, Jr.: A simplified method for the routine determination of pregnanediol and pregnanetriol in urine. Bull. Johns Hopk. Hosp. 94, 180–186 (1954).Google Scholar
  55. —, and W. R. Eberlein: Critical analysis of methods for measurement of pregnane-3α,17α, 20α-triol in human urine. Analyt. Chem. 30, 388–393 (1958).CrossRefGoogle Scholar
  56. — —, and J. Cara: Studies on the metabolism of adrenal steroids in the adrenogenital syndrome. J. clin. Endocr. 14, 409–422 (1954).PubMedCrossRefGoogle Scholar
  57. — — J. D. Smith, and A. J. McPadden: The urinary excretion of three C-21 methyl corticosteroids in the adrenogenital syndrome. J. clin. Endocr. 19, 1608–1618 (1959b).PubMedCrossRefGoogle Scholar
  58. — A. M. Di George, and M. M. Grumbach: Masculinization of the female infant associated with estrogenic therapy alone during gestation: four cases. J. clin. Endocr. 19, 1004–1011 (1959a).CrossRefGoogle Scholar
  59. —, and A. J. McPadden: Steroids during pregnancy and possible fetal consequences. Fertil. and Steril. 11, 181–186 (1960).Google Scholar
  60. —, and A. W. Root: The adrenogenital syndrome. New Engl. J. Med. 268, 1283–1289, 1342–1351, 1391–1399 (1963).PubMedCrossRefGoogle Scholar
  61. Bradbury, J. T., and W. G. Slate: A case of adrenal hyperplasia with unusual findings. J. clin. Endocr. 14, 810 (1954).Google Scholar
  62. Bradlow, H. L., and T. F. Gallagher: Metabolism of 11β-hydroxy-Δ 4-androstene-3,17-dione in man. J. Biol. Chem. 229, 505–518 (1957).PubMedGoogle Scholar
  63. — — Metabolism of 11β-hydroxy-Δ 4-androstene-3,17-dione in congenital adrenal hyperplasia. J. clin. Endocr. 19, 1575–1580 (1959).PubMedCrossRefGoogle Scholar
  64. Bratrude, T. E., and W. H. Thompson: Congenital hyperplasia of the adrenals. Staff meet. Bull. Hosp. Univ. Minn. 15, 25–43 (1943).Google Scholar
  65. Breibart, S., A. M. Bongiovanni, and W. R. Eberlein: Progestins and skeletal maturation. New Engl. J. Med. 268, 255 (1963).PubMedCrossRefGoogle Scholar
  66. Brentnall, C. P.: A case of arrhenoblastoma complicating pregnancy. J. Obstet. Gynaec. Brit. Emp. 52, 235–240 (1945).CrossRefGoogle Scholar
  67. Bricaire, H., J. Graveleau et P. Laudat: Un nouveau cas d’hyperplasie congénitale des surrénales a forme hypertensive isolement du composé “S”. Ann. Endocr. (Paris) 19, 725–733 (1958).Google Scholar
  68. Brooks, R. V.: A method for the quantitative fractionation of urinary 17-oxo steroids with some observations on steroid excretion during administration of ACTH and in the adrenogenital syndrome. Biochem. J. 68, 50–57 (1958).PubMedGoogle Scholar
  69. — The metabolism of 17α-hydroxyprogesterone in congenital adrenal hyperplasia. J. Endocr. 21, 277–286 (1960).CrossRefGoogle Scholar
  70. — D. Mattingly, I. H. Mills, and F. T. G. Prunty: Post-pubertal adrenal virilism with biochemical disturbance of the congenital type of adrenal hyperplasia. Brit. med. J. 1960I, 1294–1298.CrossRefGoogle Scholar
  71. Brooksbank, B. W. L.: Endocrinological aspects of hirsutism. Physiol. Rev. 41, 623–676 (1961).PubMedGoogle Scholar
  72. Brutschy, P.: Hochgradige Lipoidhyperplasie beider Nebennieren mit herdförmigen Kolkablagerungen bei einem Fall von Hypospadiasis penisscrotalis und doppelseitigem Kryptorchismus mit unechter akzessorischer Nebenniere am rechten Hoden (Pseudohermaphroditismus masculinus externus). Frankfurt. Z. Path. 24, 203–240 (1920).Google Scholar
  73. Bryan, G. T., B Kliman, and F. C. Bartter: Impaired aldosterone production in “saltlosing” congenital adrenal hyperplasia. Clin. Res. Proc. 10, 223 (1962).Google Scholar
  74. Burstein, S., and R. I. Dorfman: Steroid sulfatase in rat testis and adrenals. Fed. Proc. 21, 248 (1962).Google Scholar
  75. — — Determination of mammalian steroid sulfatase with 7α-H3-3β-hydroxyandrost-5-en-17-one sulfate. J. biol. Chem. 238, 1656–1660 (1963).PubMedGoogle Scholar
  76. — K. Savard, and R. I. Dorfman: The in vivo metabolism of hydrocortisone. Endocrinology 53, 88–97 (1953).PubMedCrossRefGoogle Scholar
  77. Bush, I. E., J. Swale, and J. Patterson: Analysis of steroids in adrenal venous blood and in urine in a case of virilism. Biochem. J. 62, 16P–17P (1956).Google Scholar
  78. — G. I. M. Swyer, M. I. Stern, and M. L. N. Willoughby: Adrenocortical hyperplasia: report of a case with studies of the excretion of steroid metabolites. J. Endocr. 15, 430–439 (1957).PubMedCrossRefGoogle Scholar
  79. Butler, A. M., R. A. Ross, and N. B Talbot: Probable adrenal insufficiency in an infant: report of a case. J. Pediat. 15, 831–835 (1939).CrossRefGoogle Scholar
  80. Butler, G. C., and G. F. Marrian: The isolation of pregnane-3,17,20-triol from the urine of women showing the adrenogenital syndrome. J. Biol. Chem. 119, 565–572 (1937).Google Scholar
  81. Callow, N. H., R. K. Callow, and C. W. Emmens: Colorimetric determination of substances containing the grouping-CH2 · CO- in urine extracts as an indication of androgen content. Biochem. J. 32, 1312–1331 (1938).PubMedGoogle Scholar
  82. Calvin, H. I., and S. Lieberman: Evidence that steroid sulfates serve as biosynthetic intermediates. II. In vitro conversion of pregnenolone-3H-sulfate-35S to 17α-hydroxypregnenolone-3H-sulfate-35S. Biochemistry 3, 259–264 (1964).PubMedCrossRefGoogle Scholar
  83. — R. L. Vande Wiele, and S. Lieberman: Evidence that steroid sulfates serve as biosynthetic intermediates. In vivo conversion of pregnenolone-sulfate-S35 to dehydroisoandrosterone sulfate-S35. Biochemistry 2, 648–653 (1963).PubMedCrossRefGoogle Scholar
  84. Camacho, A. M., and C. J. Migeon: Isolation, identification and quantitation of testosterone in the urine of normal adults and in patients with endocrine disorders. J. clin. Endocr. 23, 301–305 (1963).PubMedCrossRefGoogle Scholar
  85. Cara, J., F. Beas, C. Spach, and L. I. Gardner: Increased urinary and plasma etiocholanolone and related steroids in a boy with virilizing adrenal hyperplasia and periodic fever. J. Pediat. 62, 521–530 (1963).PubMedCrossRefGoogle Scholar
  86. —, J., and L. I. Gardner: Two new subvariants of virilizing adrenal hyperplasia. J. Pediat. 57, 461–470 (1960).PubMedCrossRefGoogle Scholar
  87. Carpentier, P. J.: Malformation génitale du foetus féminin aprés administration d’un noveau steroïde de synthèse pendant las grossesse. Bull. Soc. roy. belge Gynéc. Obstét. 28, 137–148 (1958).Google Scholar
  88. Carter, A. C., and E. Shorr: A study of the biological activity and the magnitude of endogenous androgen production in a case of adrenogenital syndrome. J. clin. Endocr. 8, 583 (1948).PubMedGoogle Scholar
  89. Castleman, B. (ed): Case records of the Massachusetts General Hospital. case 41121. New Engl. J. Med. 252, 496–499 (1955).CrossRefGoogle Scholar
  90. — Case records of the Massachusetts General Hospital. case 45341. New Engl. J. Med. 261, 397–402 (1959).CrossRefGoogle Scholar
  91. Cathala, J., et F. Alison: Les vomissements précoces et persistants du noveau-né par adénome cortico-surrénal congénital. Nourrisson 34, 185–189 (1946).Google Scholar
  92. Chanis, D., Jr.: Some aspects of hermaphroditism: report of a case of female pseudohermaphroditism. J. Urol. (Baltimore) 47, 508–514 (1942).Google Scholar
  93. Chaptal, J., R. Jean, P. Cristol et H. Bonnet: Augmentation des 17-hydroxycorticoïdes plasmatiques et urinaires dans un cas d’hyperplasie congénitale des surrénales sans hypertension artérielle. Identification des steroides anormaux relevant d’un deficit de la 11-beta hydroxylase. Ann. Endocr. (Paris) 20, 323–329 (1959).Google Scholar
  94. Chester Jones, I.: The adrenal cortex. Cambridge: University Press 1957.Google Scholar
  95. Childs, R, M. M. Grumbach, and J. J. Van Wyk: Virilizing adrenal hyperplasia; a genetic and hormonal study. J. clin. Invest. 35, 213–222 (1956).PubMedCrossRefGoogle Scholar
  96. Christy, N. P., E. Z. Wallace, and J. W. Jailer: The effect of intravenously-administered ACTH on plasma 17,21-dihydroxy-20-ketosteroids in normal individuals and in patients with disorders of the adrenal cortex. J. clin. Invest. 34, 899–906 (1955).PubMedCrossRefGoogle Scholar
  97. — — — Comparative effects of prednisone and of cortisone in suppressing the response of the adrenal cortex to exogenous adrenocorticotropin. J. clin. Endocr. 16, 1059–1074 (1956).PubMedCrossRefGoogle Scholar
  98. Clayton, B. E.: Some observations on adrenocorticotrophin in blood. Proc. roy. Soc. Med. 51, 558–560 (1958).PubMedGoogle Scholar
  99. Cleveland, W. W., O. C. Green, and L. Wilkins: Deaths in congenital adrenal hyperplasia. Pediatrics 29, 3–17 (1962).PubMedGoogle Scholar
  100. Cohen, R. B., W. B. Chapman, and B. Castleman: Hyperadrenocorticism (Cushing’s disease): a study of surgically resected adrenal glands. Amer. J. Path. 35, 537–561 (1959).PubMedGoogle Scholar
  101. Cohn, G. L., P. K. Bondy, and C. Castiglione: Studies on pyrogenic steroids. I. Separation, identification, and measurement of unconjugated dehydroepiandrosterone, etiocholanolone, and androsterone in human plasma. J. clin. Invest. 40, 400–407 (1961).PubMedCrossRefGoogle Scholar
  102. Cope, C. L.: Diagnostic use of adrenal inhibition in Cushing’s syndrome. Brit. med. J. 1956 II, 193–197.Google Scholar
  103. — Steroid metabolism in a case of congenital adrenal hyperplasia. Brit. med. J. 1959I, 815–817.Google Scholar
  104. —, C. L., and R. J. Harrison: Effect of 9α-fluorohydrocortisone on adrenal hyperfunction in Cushing’s syndrome. Brit. med. J. 1955II, 457–460.Google Scholar
  105. Coppage, W.S., Jr., and G. W. Liddle: Metabolic studies with a steroid isolated from the urine of patients with “salt.losing” congenital adrenal hyperplasia. J. clin. Endocr. 20, 729–734 (1960).PubMedCrossRefGoogle Scholar
  106. Cost, W. S.: Quantitative estimation of adrenocortical hormones and their α-ketolic metabolites in urine. II. Pathological adrenocortical hyperfunction. Acta endocr. (Kbh.) 42, 39–52 (1963).Google Scholar
  107. Cotte, G.: Plastic operations for sexual ambiguity. J. Mt Sinai Hosp. 14, 170–174 (1947).Google Scholar
  108. Cox, R. I.: The separation and quantitative estimation of pregnane-3α,17α,20α-triol, pregnane-3α,17α,20α-triol-11-one, and other urinary acetaldehydogenic steroids. J. Biol. Chem. 234, 1693–1697 (1959).PubMedGoogle Scholar
  109. Cushing, H.: The basophil adenomas of the pituitary body and their clinical manifestations (Pituitary basophilism). Bull. Johns Hopk. Hosp. 50, 137–195 (1932).Google Scholar
  110. Danowski, T. S.: Clinical endocrinology, vol. IV, Adrenal cortex and medulla, p. 341–343. Baltimore: Williams & Wilkins Co. 1962a.Google Scholar
  111. — Clinical endocrinology, vol. IV, Adrenal cortex and medulla, p.78–83, 90–94. Baltimore: Williams & Wilkins Co. 1962b.Google Scholar
  112. — Clinical endocrinology, vol. IV, Adrenal cortex and medulla, p.84–89. Baltimore: Williams & Wilkins Co. 1962c.Google Scholar
  113. — Clinical endocrinology, vol. IV, Adrenal cortex and medulla, p. 155–157. Baltimore: Williams & Wilkins Co. 1962d.Google Scholar
  114. Davies, B. M. A.: Blood corticotrophin in normal adults and in patients with Cushing’s syndrome. Acta endocr. (Kbh.) 45, 55–67 (1964).Google Scholar
  115. Debray, Ch., É. É. Beaulieu et M.-F. Jayle: Cancer de la cortico-surrémale etude cliníque, radiologique, biochimique et histologique d’un cas. Methode simple de dépistage. Ann. Endocr. (Paris) 15, 895–909 (1954).Google Scholar
  116. Decourt, M. J., et M. F. Jayle: Pseudohermaphrodisme masculin avec hyperandrogénie cortico-surrénale. Ann. Endocr. (Paris) 21, 528–532 (1960).Google Scholar
  117. — —, et É. É. Baulieu: Virilisme cliniquement tardif avec excrétion de prégnanetriol et insuffisance de la production du cortisol. Ann. Endocr. (Paris) 18, 416–422 (1957).Google Scholar
  118. Dempsey, H., and S. Richardson Hill, Jr.: Studies in man on gonadotropin responsive feminizing adrenal cortical neoplasia. J. clin. Endocr. 23, 173–180 (1963).PubMedCrossRefGoogle Scholar
  119. Diczfalusy, E., and R. Luft: A qualitative study on the oestrogens excreted by a male patient with an adrenal cortical tumour. Acta endocr. (Kbh.) 9, 327–332 (1952).Google Scholar
  120. Dignam, W. J., R. J. Pion, E. J. Lamb, and H. H. Simmer: Plasma androgens in women. II. Patients with polycystic ovaries and hirsutism. Acta endocr. (Kbh.) 45, 254–271 (1964).Google Scholar
  121. Dijkhuizen, R. K., and E. Behr: Adrenal hypertrophy in infants. A new clinical entity of the neonatal period. Acta paediat. (Uppsala) 27, 279–295 (1940).CrossRefGoogle Scholar
  122. Doe, R. P., J. A. Vennes, and E. B. Flink: Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing’s syndrome. J. clin. Endocr. 20, 253–265 (1960).PubMedCrossRefGoogle Scholar
  123. Dohan, F. C., E. Rose, J. W. Eiman, E. M. Richardson, and H. Zintel: Increased urinary estrogen excretion associated with adrenal tumors: Report of four cases. J. clin. Endocr. 13, 415–428 (1953).PubMedCrossRefGoogle Scholar
  124. Dominguez, O. V.: Biosynthesis of steroids by testicular tumors complicating congenital adrenocortical hyperplasia. J. clin. Endocr. 21, 663–674 (1961).PubMedCrossRefGoogle Scholar
  125. Dorfman, R. I.: Neutral steroid hormone metabolites. Recent Progr. Hormone Res. 9, 5–26 (1954).Google Scholar
  126. Dorfman, R. I., E. Forchielli, S. Ichii, and W. Futterweit: Evaluation of androgens and estrogens in normal and abnormal states. Soc. Mexicana de Nutricion y Endocrinol. 3rd Reunion Anual, San José Purua, Mich., Mexico Nov. 1962, p. 141–150.Google Scholar
  127. Dyrenfurth, I., A. J. Blair, J. C. Beck, and E. H. Venning: Studies in patients with adrenocortical hyperfunction. I. The effect of corticotropin on levels of corticosteroids, 17-ketosteroids and aldosterone. J. clin. Endocr. 20, 735–750 (1960).PubMedCrossRefGoogle Scholar
  128. —, S. Sybulski, V. Notchev, J. C. Beck, and E. H. Venning: Urinary corticosteroid excretion pattern in patients with adrenocortical dysfunction. J. clin. Endocr. 18, 391–408 (1958).PubMedCrossRefGoogle Scholar
  129. Eberlein W. R.: The salt-losing form of congenital adrenal hyperplasia. Pediatrics 21, 667–672 (1958).PubMedGoogle Scholar
  130. —, and A. M. Bongiovanni: Congenital adrenal hyperplasia with hypertension: unusual steroid pattern in blood and urine. J. clin. Endocr. 15, 1531–1534 (1955a).PubMedCrossRefGoogle Scholar
  131. — — Partial characterization of urinary adrenocortical steroids in adrenal hyperplasia. J. clin. Invest. 34, 1337–1343 (1955b).PubMedCrossRefGoogle Scholar
  132. — — Plasma and urinary corticosteroids in the hypertensive from of congenital adrenal hyperplasia. J. Biol. Chem. 223, 85–94 (1956).PubMedGoogle Scholar
  133. — — Steroid metabolism in the “salt-losing” form of congenital adrenal hyperplasia. J. clin. Invest. 37, 889–890 (1958).Google Scholar
  134. Epstein, J. A., and H. S. Kupperman: Dexamethasone therapy in the adrenogenital syndrome—a comparative study. J. clin. Endocr. 19, 1503–1506 (1959).PubMedCrossRefGoogle Scholar
  135. Escamilla, R. F., and S. G. Johnson: Successful surgical removal of adrenal cortical adenoma causing virilism for 30 years. Postgrad. Med. 11, 272–277 (1952).PubMedGoogle Scholar
  136. Fallesen, M.: Binyrebarkensufficiens hos et spaedbarn. Nord. Med. 39, 1573–1574 (1948).PubMedGoogle Scholar
  137. Felioissimo, P. X. J., e J. M. De Abreu: Sobre un caso de arrhenoblastoma do ovario e gravidez topica simultanea. Virilisação da gestante e do feto feminino. Rev. Obstet. Ginec. S. Paulo 1, 356–377 (1938).Google Scholar
  138. Fieser, L. F., and M. Fieser: Steroids. New York: Reinhold 1959.Google Scholar
  139. Fine, E., H. M. Levin, and E. L. Mcconnell, Jr.: Masculinization of female infants associated with norethindrone acetate. Obstet. and Gynec. 22, 210–213 (1963).Google Scholar
  140. Finkelstein, M.: Pregnanetriolone, abnormal urinary steroid. In: R. I. Dorfman (ed.), Methods in hormonal research, vol. 1, p. 169–197. New York: Academic Press 1962.Google Scholar
  141. — The adrenogenital syndrome. New Engl. J. Med. 270, 260–261 (1964).Google Scholar
  142. —, and R. I. Cox: Method for simultaneous estimation of pregnane-3α,17α,20α-triol and pregnane-3α,17α,20α-triol-11-one in urine. Proc. Soc. Exp. Biol. (N. Y.) 95, 297–300 (1957).Google Scholar
  143. —, J. v. Euw u. T. Reichstein: Isolierung von 3,17,20α-trioxypregnanon-(11) aus pathologischem menschlichem Harn. Helv. chim. Acta 36, 1266–1277 (1953).CrossRefGoogle Scholar
  144. — E. Forchielli, and R. I. Dorfman: Estimation of testosterone in human plasma. J. clin. Endocr. 21, 98–101 (1961).PubMedCrossRefGoogle Scholar
  145. —, and S. Goldberg: A test for qualitative and quantitative estimation of pregnane-3α,17α,20α-triol-11-one in urine and its significance in adrenal disturbances. J. clin. Endocr. 17, 1063–1070 (1957).PubMedCrossRefGoogle Scholar
  146. —, and J. Schoenberger: Urinary steroids in 10 cases of adrenal carcinoma, with special reference to pregnane-3α,17α,20α-triol-11-one. J. clin. Endocr. 19, 608–612 (1959).PubMedCrossRefGoogle Scholar
  147. Forbes, A. P., and F. Albright: A comparison of the 17-ketosteroid excretion in Cushing’s syndrome associated with adrenal tumor and with adrenal hyperplasia. J. clin. Endocr. 11, 926–935 (1951).PubMedCrossRefGoogle Scholar
  148. Forchielli, E., G. Sorcini, M. Stylianou Nightingale, N. Brust, R. I. Dorfman, W. H. Perloff, and G. Jacobson: Testosterone in human plasma. Analyt. Biochem. 5, 416–421 (1963).PubMedCrossRefGoogle Scholar
  149. Fotherby, K., and D. N. Love: An investigation of the possible precursors of urinary pregnanetriol. J. Endocr. 21, 129–135 (1960).PubMedCrossRefGoogle Scholar
  150. Frank, R. T.: A suggested test for functional cortical adrenal tumor. Proc. Soc. exp. Biol. (N. Y.) 31, 1204–1206 (1933).Google Scholar
  151. Fujita, T., H. Ibayasi, K. Motohasi, T. Uchikawa, and S. Okinaka: Clinical applications of urinary ACTH assay. J. clin. Endocr. 23, 143–148 (1963).PubMedCrossRefGoogle Scholar
  152. Fukushima, D. K., H. L. Bradlow, K. Dobriner, and T. F. Gallagher: The fate of testosterone infused intravenously in man. J. Biol. Chem. 206, 863–874 (1954).PubMedGoogle Scholar
  153. — — L. Hellman and T. F. Gallagher: Further studies of 21-deoxyhydrocortisone-4-C14 in man. J. clin. Endocr. 19, 393–402 (1959).PubMedCrossRefGoogle Scholar
  154. — — — — Origin of pregnanetriol in a patient with adrenal carcinoma. J. clin. Endocr. 22, 765–772 (1962).PubMedCrossRefGoogle Scholar
  155. — — — B. Zummoff, and T. F. Gallagher: Study of 17-hydroxyprogesterone-4-C14 in man. J. clin. Endocr. 21, 765–778 (1961a).PubMedCrossRefGoogle Scholar
  156. Fukushima, D.K., K. Dobriner, and T. F. Gallagher: Metabolic studies with deuterium steroid hormones. Fed. Proc. 10, 185 (1951).Google Scholar
  157. —, and T. F. Gallagher: Steroid isolation studies in congenital adrenal hyperplasia. J. Biol. Chem. 229, 85–92 (1957).PubMedGoogle Scholar
  158. — — Absence of 21-dehydroxylation in congenital adrenal hyperplasia. J. clin. Endocr. 18, 694–698 (1958).PubMedCrossRefGoogle Scholar
  159. — — Steroid production in “nonfunctioning” adrenal cortical tumor. J. clin. Endocr. 23, 923–927 (1963).PubMedCrossRefGoogle Scholar
  160. — M. Smulowitz, and K. I. H. Williams: Δ 5-pregnene-3α,16α,20α-triol and related steroids in adrenocortical carcinoma. J. Biol. Chem. 236, 3147–3150 (1961 b).Google Scholar
  161. Gallagher, T. F.: On alterations in adrenal function, especially with adrenocortical carcinoma. Cancer Res. 17, 520–529 (1957).PubMedGoogle Scholar
  162. — A. Kappas, H. Spencer, and D. Lazlo: Influence of invasiveness, hormones, and amphenone on steroids in adrenal carcinoma. Science 124, 487–489 (1956).PubMedCrossRefGoogle Scholar
  163. Gandy, H. M., and E. H. Keutmann: 11β-Hydroxylase deficiency in congenital adrenal hyperplasia in the absence of hypertension. Amer. J. Dis. Child. 96, 519 (1958).Google Scholar
  164. — —, and A. J. Izzo: Characterization of urinary steroids in adrenal hyperplasia: isolation of metabolites of cortisol, compound S, and desoxycorticosterone from a normotensive patient with adrenogenital syndrome. J. clin. Invest. 39, 364–377 (1960).PubMedCrossRefGoogle Scholar
  165. Gardner, L. I.: Increased plasma 17-ketosteroid concentration in congenital adrenal hyperplasia. Proc. Soc. expo Biol. (N. Y.) 83, 251–252 (1953).Google Scholar
  166. —, and C. J. Migeon: Urinary dehydroisoandrosterone in hyperadrenocorticism: influence of cortisone, hydrocortisone, and ACTH. J. clin. Endocr. 12, 1117–1139 (1952).PubMedCrossRefGoogle Scholar
  167. — — Unusual plasma 17-ketosteroid pattern in a boy with congenital adrenal hyperplasia and periodic fever. J. clin. Endocr. 19, 266–269 (1959).PubMedCrossRefGoogle Scholar
  168. — R. C. Sniffen, A. S. Zygmuntowicz, and N. B. Talbot: Follow-up studies in a boy with mixed adrenal cortical disease. Pediatrics 5, 808–823 (1950).PubMedGoogle Scholar
  169. Geller, J., A. S. Alvarez, A. Gutman, A. De Freitas, J. L. Gabrilove, and L. J. Soffer: Effect of prednisone on adrenal responsiveness to corticotropin in normal subjects and in patients with treated and untreated Cushing’s syndrome. J. clin. Endocr. 18, 409–416 (1958).PubMedCrossRefGoogle Scholar
  170. Gierke, E. v.: Über interrenalismus und interrenale Intoxikation. Verh. dtsch. path. Ges. 23, 449–456 (1928).Google Scholar
  171. Gilbert-Dreyfus, M. M., J.-C. Savoie, J. Sebaoun, F. Dray, Y. Adam, R. Rapapport et A. Chabaud: Etude d’un cas d’hypercorticisme congénital par anomalie de la 11β-Phydroxylase. Identification des composés “S”, “DOC” et “B”. Ann. Endocr. (Paris) 20, 754–760 (1959).Google Scholar
  172. Gillman, J.: The development of the gonads in man, with a consideration of the role of fetal endocrines and the histogenesis of ovarian tumors. Contr. Embryol. Carneg. Instn. 32, 83–131 (1948).Google Scholar
  173. Glenister, T. W.: The origin and fate of the urethral plate in man. J. Anat. (Lond.) 88, 413–425 (1954).Google Scholar
  174. Glenn, J. F., and W. H. Boyce: Adrenogenitalism with testicular adrenal rests simulating interstitial cell tumor. Trans. Amer. Ass. gen.-urin. Surg. 54, 59–66 (1962).Google Scholar
  175. Gold, A. P., and A. F. Michael, Jr.: Testosterone-induced female pseudohermaphrodism. J. Pediat. 52, 279–283 (1958).PubMedCrossRefGoogle Scholar
  176. Goldman, A. S., A. M. Bongiovanni, W. C. Yakovic, and A. Prader: Study of Δ 5,3β-hydroxysteroid dehydrogenase in normal, hyperplastic and neoplastic adrenal cortical tissue. J. clin. Endocr. 24, 894–909 (1964).PubMedCrossRefGoogle Scholar
  177. Goldstein, M., M. Gut, and R. I. Dorfman: Conversion of pregnenolone to dehydroepiandrosterone. Biochim. biophys. Acta (Amst.) 38, 190–191 (1960).CrossRefGoogle Scholar
  178. Goldzieher, J. W., and K. Rodgers: Clitoral hypertrophy in one of nonidentical twins. Amer. J. Obstet. Gynec. 86, 882–885 (1963).PubMedGoogle Scholar
  179. Gonzales, R. F., and L. I. Gardner: Congenital adrenal hyperplasia with associated episodes resembling histamine poisoning. Pediatrics 17, 524–531 (1956).PubMedGoogle Scholar
  180. Graeff, J. De, and A. J. Moolenaar: Effect of cortisone on the excretion of aldosterone in virilising adrenal hyperplasia. Lancet 1960I, 854–855.CrossRefGoogle Scholar
  181. Gray, C. H., J. M. Greenaway, N. J. Holness, and D. A. Shaw: The metabolism of (4-14C) cortisol in a patient with Cushing’s syndrome. J. Endocr. 24, 199–214 (1962).CrossRefGoogle Scholar
  182. Green, O. C., C. J. Migeon, and L. Wilkins: Urinary steroids in the hypertensive from of congenital adrenal hyperplasia. J. clin. Endocr. 20, 929–946 (1960).PubMedCrossRefGoogle Scholar
  183. Greenblatt, R. B.: Clinical aspects of sexual abnormalities in man. Recent Progr. Hormone Res. 14, 335–404 (1958).PubMedGoogle Scholar
  184. — J. M. Manautou, S. L. Clark, and A. P. Rosenberg: Suppression of adrenal cortical activity in treatment of menstrual disorders. Metabolism 7, 25–39 (1958).PubMedGoogle Scholar
  185. Groen, A., J. A. De Vries, and D. De Wied: Urinary excretion of 17-ketosteroids in patients with adrenogenital syndrome. Acta endocr. (Kbh.) 18, 530–535 (1955).Google Scholar
  186. Gross, R. E., and I. A. Meeker, Jr.: Abnormalities of sexual development. Observations from 75 cases. Pediatrics 16, 303–324 (1955).PubMedGoogle Scholar
  187. Grumbach, M. M., and J. R. Ducharme: The effect of androgen on fetal sexual development. Fertil. and Steril. 11, 157–180 (1960).Google Scholar
  188. — —, and R. E. Moloshok: On the fetal masculinizing action of certain oral progestins. J. clin. Endocr. 19, 1369–1380 (1959).PubMedCrossRefGoogle Scholar
  189. Grumbach, M. M., J. J. van Wyk, and L. Wilkins: Chromosomal sex in gonadal dysgenesis (ovarian agenesis): relationship to male pseudohermaphrodism and theories of human sex differentiation. J. clin. Endocr. 15, 1161–1193 (1955).PubMedCrossRefGoogle Scholar
  190. Grunwaldt, E., and T. Bates: Nonadrenal female pseudohermaphrodism after administration of testosterone to mother during pregnancy. Pediatrics 20, 503–505 (1957).PubMedGoogle Scholar
  191. Guignard-de Maeyer, J.A., J. F. Crigler, Jr., and N. I. Gold: An alteration in cortisol metabolism in patients with Cushing’s syndrome and bilateral adrenal hyperplasia. J. clin. Endocr. 23, 1271–1284 (1963).CrossRefGoogle Scholar
  192. Guillon, J., J. Colas, R. Trichereau, G. Delumeau et É.- É. Baulieu: Tumeur surrénale virilisante. Étude des 17-cétostéroides dans la tumeur, dans le sang veineux surrénalien et périphérique et dans les urines. Ann. Endocr. (Paris) 22, 331–335 (1961).Google Scholar
  193. Guin, G. H., and E. F. Gilbert: Cushing’s syndrome in children associated with adrenal cortical carcinoma. Amer. J. Dis. Child. 92, 297–307 (1956).Google Scholar
  194. Guinet, P., J. Perrin, R. Béthoux, R. Mornex et J.-P. Pédard: Une observation de cortico-surrenalome malin avec gynecomastie. Ann. Endocr. (Paris) 17, 69–74 (1956).Google Scholar
  195. Gurtner, H. P.: Pseudohermaphroditismus masculinus und kongenitale Nebennierenrindenhyperplasie. Virchows Arch. path. Anat. 326, 409–443 (1955).CrossRefGoogle Scholar
  196. Hamilton, W. J., J. D. Boyd, and H. W. Mossman: Human embryology. Baltimore: Williams & Wilkins Co. 1947.Google Scholar
  197. Hamwi, G. J., G. Gwinup, J. H. Mostow, and P. K. Besch: Activation of testicular rest tissue by prolonged excessive ACTH production. J. clin. Endocr. 23, 861–869 (1963).PubMedCrossRefGoogle Scholar
  198. — R. A. Serbin, and F. A. Kruger: Does adrenocortical hyperplasia result in adrenocortical carcinoma? New Engl. J. Med. 257, 1153–1157 (1957).PubMedCrossRefGoogle Scholar
  199. Hayles, A. B., and R. B. Nolan: Female pseudohermaphroditism: report of a case in an infant born of a mother receiving methyltestosterone during pregnancy. Proc. Mayo Clin. 32, 41–44 (1957).Google Scholar
  200. — — Masculinization of female fetus, possibly related to administration of progesterone during pregnancy. Report of two cases. Proc. Mayo Clin. 33, 200–203 (1958).Google Scholar
  201. Haynes, E., H. P. Thomas, and M. S. Wheeler: Pseudohermaphroditism with psychosis. Med. Rec. (N. Y.) 154, 307–310 (1941).Google Scholar
  202. Healy, C. E., and C. C. Guy: Pseudohermaphroditismus masculinis externus associated with suprarenal hyperplasia and vascular hypertension. Arch. Path. 12, 541–561 (1931).Google Scholar
  203. Hechter, O., and G. Pincus: Genesis of adrenocortical secretion. Physiol. Rev. 34, 459–596 (1954).PubMedGoogle Scholar
  204. Hedinger, C.: Beidseitige Hodentumoren und kongenitales adrenogenitales Syndrom (Leydig- Zellen oder Nebennierenrindengewebe?) Schweiz. Z. allg. Path. 17, 743–750 (1954).PubMedGoogle Scholar
  205. Hernando, L., J. Crabbé, E. J. Ross, W. J. Reddy, A. E. Renold, D. H. Nelson, and G. W. Thorn: Clinical experience with a physicochemical method for estimation of aldosterone in urine. Metabolism 6, 518–543 (1957).PubMedGoogle Scholar
  206. Hertz, R., D. M. Bergenstal, H. A. Lubs, and S. J. Jackson: Observations on adrenal carcinoma with special reference to the effects of amphenone. Cancer (Philad.) 10, 765–776 (1957).CrossRefGoogle Scholar
  207. Higgins, G. A., W. E. Brownlee, and F. A. Mantz, Jr.: Feminizing tumors of the adrenal cortex. Amer. Surg. 22, 56–79 (1956).Google Scholar
  208. Hirschmann, H., and F. B. Hirschmann: Steroid excretion in a case of adrenocortical carcinoma. II. An examination of the non-ketonic fraction precipitable with digitonin. J. Biol. Chem. 157, 601–612 (1945).Google Scholar
  209. — — Steroid excretion in a case of adrenogenital carcinoma. V. Δ 5-pregnenetriol-3β,17α,20α. J. Biol. Chem. 187, 137–146 (1950).PubMedGoogle Scholar
  210. Hoffman, F., C. Overzier, and G. Uhde: Zur Frage der hormonalen Erzeugung fötaler Zwitterbildungen beirn Menschen. Geburtsh. u. Frauenheilk. 15, 1061–1070 (1955).Google Scholar
  211. Hollander, N., and V. P. Hollander: The microdetermination of testosterone in human spermatic vein blood. J. clin. Endocr. 18, 966–971 (1958).PubMedCrossRefGoogle Scholar
  212. Horwith, M., and P. E. Stokes: Cushing’s syndrome, experience with total adrenalectomy. Advanc. intern. Med. 10, 259–295 (1960).Google Scholar
  213. Howard, F. S., and F. Hinman, Jr.: Female pseudohermaphroditism with supplementary phallic urethra: Report of two cases. J. Urol. (Baltimore) 65, 439–452 (1951).Google Scholar
  214. Hudson, B., J. Coghlan, A. Dulmanis, M. Wintour, and I. Ekkel: The estimation of testosterone in biological fluids. I. Testosterone in plasma. Aust. J. expo Biol. med. Sci. 41, 235–246 (1963).CrossRefGoogle Scholar
  215. Ibayashi, H., M. Nakamura, S. Murakawa, T. Uchikawa, T. Tanioka, and K. Nakao: The determination of urinary testosterone using thin layer chromatography and gas chromatography. Steroids 3, 559–568 (1964).CrossRefGoogle Scholar
  216. Ichii, S., E. Forchielli, C. E. Cassidy, C. B. Rosoff, and R. I. Dorfman: Biosynthesis of androgens by homogenates of normal and abnormal human adrenal glands. Biochem. biophys. Res. Commun. 9, 344–348 (1962).PubMedCrossRefGoogle Scholar
  217. Iversen, T.: Congenital adrenocortical hyperplasia with disturbed electrolyte regulation, “dysadrenocorticism”. Pediatrics 16, 875–901 (1955).PubMedGoogle Scholar
  218. Jacobsohn, G. M.: Isolation of 5-pregnene-diol from the urine of a patient with congenital adrenocortical hyperplasia. J. clin. Endocr. 22, 859–860 (1962).PubMedGoogle Scholar
  219. Jacobziner, H., and A. Gorfinkel: Familial congenital adrenal syndrome. Amer. J. Dis. Child. 52, 308–320 (1936).Google Scholar
  220. Jailer, J. W.: Virilism. Bull. N. Y. Acad. Med. 29, 377–394 (1953).PubMedGoogle Scholar
  221. — J. J. Gold and G. F. Cahill: Hirsutism as the only clinical manifestation of an adrenal adenoma. Amer. J. Obstet. Gynec. 67, 201–205 (1954a).PubMedGoogle Scholar
  222. — —, and E. Z. Wallace: Evaluation of “cortisone test” as a diagnostic aid in differentiating adrenal hyperplasia from adrenal neoplasia. Amer. J. Med. 16, 340–345 (1954b).PubMedCrossRefGoogle Scholar
  223. — — R. Vande Wiele, and S. Lieberman: 17α-hydroxyprogesterone and 21-desoxyhydrocortisone; their metabolism and possible role in congenital virilism. J. clin. Invest. 34, 1639–1646 (1955).PubMedCrossRefGoogle Scholar
  224. — D. Longson, and N. P. Christy: Studies in Cushing’s syndrome. II. Adrenal weight-maintaining activity in the plasma of patients with Cushing’s syndrome. J. clin. Invest. 36, 1608–1614 (1957).PubMedCrossRefGoogle Scholar
  225. — J. Louchart and G. F. Cahill: Adrenal virilism. II. Metabolic studies. J. clin. Invest. 31, 880–884 (1952).PubMedCrossRefGoogle Scholar
  226. — — J. J. Gold, and A. I. Knowlton: The effect of cortisone on the urinary excretion of 17-ketosteroids in patients with Cushing’s syndrome. J. clin. Invest. 32, 449–452 (1953).PubMedCrossRefGoogle Scholar
  227. —, and E. Z. Wallace: The effect of intravenously administered hydrocortisone on the urinary 17-keto-steroids in patients with adrenal virilism. Ann. N. Y. Acad. Sci. 61, 442–447 (1955).PubMedCrossRefGoogle Scholar
  228. — R. W. Vande Wiele, N. P. Christy, and S. Lieberman: Studies in Cushing’s syndrome. III. Urinary 17-ketosteroids in patients with bilateral adrenal cortical hyperplasia. J. clin. Invest. 38, 357–365 (1959).PubMedCrossRefGoogle Scholar
  229. James, V. H. T.: The excretion of individual 17-oxosteroids in Cushing’s syndrome. J. Endocr. 23, 119–127 (1991).CrossRefGoogle Scholar
  230. Jaoudé, F. A., É.-É. Baulieu et M. F. Jayle: Fractionnement par chromatographie sur papier des 17-cetosteroïdes neutres urinaires au cours de l’hyperplasie virilisante congenitale corticosurrénale: contribution à l’étude de leur biogénèse. Acta endocr. (Kbh.) 26, 30–42 (1957).Google Scholar
  231. Javert, C. T., and W. F. Finn: Arrhenoblastoma: the incidence of malignancy and the relationship to pregnancy, to sterility and to treatment. Cancer (Philad.) 4, 60–77 (1951).CrossRefGoogle Scholar
  232. Jayle, M. F., S. H. Weinmann, É.-É. Baulieu et V. Vallin: Virilisme post-pubertaire discret par deficience de l’hydroxylation en C21. Acta endocr. (Kbh.) 29, 513–524 (1958).Google Scholar
  233. Jenkins, J. S., and A. W. Spence: Effect of corticotropin and 9α-fluorohydrocortisone on urinary steroids in Cushing’s syndrome. J. clin. Endocr. 17, 621–631 (1957).PubMedCrossRefGoogle Scholar
  234. Jensen, C. C., and S.-I. Björklund: The adrenogenital syndrome. Discussion of a case with special reference to the paternal and maternal steroid patterns. Acta endocr. (Kbh.) 22, 42–48 (1956).Google Scholar
  235. Jeune, M., et A. Charrat: Les syndromes corticosurrénaux congénitaux l’hyperplasia surrénale congénitale. Pédiatrie 8, 307–355 (1953).PubMedGoogle Scholar
  236. Jones, H. W., Jr., and G. E. S. Jones: The gynecological aspects of adrenal hyperplasia and allied disorders. Amer. J. Obstet. Gynec. 68, 1330–1365 (1954).PubMedGoogle Scholar
  237. —, Jr., and L. Wilkins: The genital anomaly associated with prenatal exposure to progestogens. Fertil. and Steril. 11, 148–156 (1960).Google Scholar
  238. Jost, A.: Problems of fetal endocrinology: gonadal and hypophyseal hormones. Recent Progr. Hormone Res. 8, 379–418 (1953).Google Scholar
  239. Kaplan, N. M.: Male pseudohermaphroditism. Report of a case, with observations on pathogenesis. New Engl. J. Med. 261, 641–644 (1959).PubMedCrossRefGoogle Scholar
  240. Kappas, A., K. Dobriner, and T. F. Gallagher: Studies in steroid metabolism. XXVII. A comparison of the steroid response to ACTH and cortisone in normal young men. J. clin. Invest. 34, 1559–1565 (1955).PubMedCrossRefGoogle Scholar
  241. Kappas, A., and T. F. Gallagher: Studies in steroid metabolism. XXVIII. The α-ketosteroid excretion pattern in normal females and the response to ACTH. J. clin. Invest. 34, 1566–1572 (1955).PubMedCrossRefGoogle Scholar
  242. —, L. Hellman, D. K. Fukushima, and T. F. Gallagher: The pyrogenic effect of etiocholanolone. J. clin. Endocr. 17, 451–454 (1957).PubMedCrossRefGoogle Scholar
  243. Keller, M.: Increased urinary estrogen and 17-ketosteroid excretion associated with adrenal adenoma. Isolation of cholestane-dione-3,6 from the tumor. J. clin. Endocr. 16, 1075–1088 (1956).PubMedCrossRefGoogle Scholar
  244. — A. Hauser, and A. Walser: Virilizing adrenal adenoma associated with increased urinary excretion of estrogens and 17-keto steroids. Isolation of the steroids from the tumor. J. clin. Endocr. 18, 1384–1398 (1958).PubMedCrossRefGoogle Scholar
  245. Kelley, V. C., R. S. Ely, and R. B. Raile: Metabolic studies in patients with congenital adrenal hyperplasia. Effects of cortisone therapy. J. clin. Endocr. 12, 1140–1162 (1952).PubMedCrossRefGoogle Scholar
  246. — — — Hormone patterns in patients with congenital adrenal hyperplasia. Pediatrics 12, 541–548 (1953).PubMedGoogle Scholar
  247. Kinsell, L. W., and H. Lisser: Adrenal cortical tumor causing hirsutism without other evidence of virilization. J. clin. Endocr. 12, 50–54 (1952).PubMedCrossRefGoogle Scholar
  248. Klein, R.: Evidence for and against the existence of a salt-losing hormone. J. Pediat. 57, 452–460 (1960).PubMedCrossRefGoogle Scholar
  249. — P. Taylor, C. Papadatos, Z. Laron, D. Keele, J. Fortunato, C. Byers, and C. Billings: Sodium losing material in human urine. Proc. Soc. expo Biol. (N. Y.). 98, 863–866 (1958).Google Scholar
  250. Knudson, A. G., Jr.: Mixed adrenal disease of infancy. J. Pediat. 39, 408–423 (1951).PubMedCrossRefGoogle Scholar
  251. Koff, A. K.: Development of the vagina in the human fetus. Contr. Embryol. Carneg. Instn 24, 59–92 (1933).Google Scholar
  252. Kovacić, N., J. Matovinovrć, and M. Prosenjak: Qualitative differences in urinary 17-ketosteroid excretion in patients with Cushing’s syndrome. Acta endocr. (Kbh.) 24, 393–401 (1957).Google Scholar
  253. Laidlaw, J. C., W. J. Reddy, D. Jenkins, N. Abu Haydar, A. E. Renold, and G. W. Thorn: Advances in the diagnosis of altered states of adrenocortical function. New Engl. J. Med. 253, 747–753 (1955).PubMedCrossRefGoogle Scholar
  254. Lamb, E. J., W. Dignam, R. J. Pion, and H. H. Simmer: Plasma androgens in women. I. Normal and non-hirsute females, oophorectomized and adrenalectomized patients. Acta endocr. (Kbh.) 45, 243–253 (1964).Google Scholar
  255. Landau, R. L.: The diagnosis of adrenal cortical tumors. Proc. 2nd nat. Cancer Conf. 1952, 1, 309–321 (1954).Google Scholar
  256. — B. F. Stimmel, E. Humphreys, and D. E. Clark: Gynecomastia and retarded sexual development resulting from a longstanding estrogen-secreting adrenal tumor. J. clin. Endocr. 14, 1097–1112 (1954).PubMedCrossRefGoogle Scholar
  257. Landing, B. H.: Hilar-cell proliferation in the adrenogenital syndrome. J. clin. Endocr. 14, 245–247 (1954).PubMedCrossRefGoogle Scholar
  258. —, and E. Gold: The occurrence and significance of Leydig cell proliferation in familial adrenal cortical hyperplasia. J. clin. Endocr. 11, 1436–1453 (1951).PubMedCrossRefGoogle Scholar
  259. Langecker, H.: Das Schicksal des 17α-Oxyprogesterons und seines 17-Capronates in menschlichen Organismus. II. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 225, 309–313 (1955).Google Scholar
  260. — 17α-Oxyprogesteron und Nebennierenrindenhyperplasie. III. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 227, 474–480 (1956).CrossRefGoogle Scholar
  261. —, u. W. Prescher: Das Schicksal von 17-α-Oxyprogesteron im menschlichen Organismus. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 223, 306–310 (1954).Google Scholar
  262. Lanman, J. T.: The fetal zone of the adrenal gland. Its developmental course, comparative anatomy, and possible physiologic functions. Medicine (Baltimore) 32, 389–430 (1953).CrossRefGoogle Scholar
  263. —, and L. M. Silverman: In vitro steroidogenesis in the human neonatal adrenal gland, including observations on human adult and monkey adrenal glands. Endocrinology 60, 433–445 (1957).PubMedCrossRefGoogle Scholar
  264. Levine, S. Z.: Conference at the New York Hospital — Cornell Medical Center. Case 2. Congenital adrenocortical insufficiency with virilism. J. Pediat. 34, 768–777 (1949).CrossRefGoogle Scholar
  265. Lewis, R. A., and L. Wilkins: The effect of adrenocorticotrophic hormone in congenital adrenal hyperplasia with virilism and in Cushing’s syndrome treated with methyl testosterone. J. clin. Invest. 28, 394–400 (1949).CrossRefGoogle Scholar
  266. Liddle, G. W.: Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J. clin. Endocr. 20, 1539–1560 (1960).PubMedCrossRefGoogle Scholar
  267. Lieberman, A. H., and J. A. Luetscher: Some effects of abnormalities of pituitary, adrenal or thyroid function on excretion of aldosterone and the response to corticotropin or sodium deprivation. J. clin. Endocr. 20, 1004–1016 (1960).PubMedCrossRefGoogle Scholar
  268. Lieberman, S., and K. Dobriner: The isolation of pregnanediol-3α,17-one-20 from human urine. J. Biol. Chem. 161, 269–278 (1945).PubMedGoogle Scholar
  269. Lindner, H. R.: Androgens and related compounds in the spermatic vein blood of domestic animals. I. Neutral steroids secreted by the bull testis. J. Endocr. 23, 139–159 (1961).PubMedCrossRefGoogle Scholar
  270. Lindsay, A. E., C. J. Migeon, C. A. Nugent, and H. Brown: The diagnostic value of plasma and urinary 17-hydroxycorticosteroid determinations in Cushing’s syndrome. Amer. J. Med. 20, 15–22 (1956).PubMedCrossRefGoogle Scholar
  271. Lipsett, M. B.: Precursors of etiocholanolone and androsterone in adrenal carcinoma. Proc. Soc. exp. Biol. (N.Y.) 107, 439–442 (1961).Google Scholar
  272. —, and B. Damast: Excretion of pregnane-3α,17α,21-triol-20-one (tetrahydro S) by patients with adrenocortical carcinoma. Proc. Soc. exp. Biol. (N. Y.) 99, 285–287 (1958).Google Scholar
  273. —, and B. D. Riter: Urinary steroids in post-natal adrenal hyperplasia with virilism. Acta endocr. (Kbh.) 38, 481–489 (1961).Google Scholar
  274. Lloyd, C. W.: Virilization and hirsutism. In: C. W. Lloyd (ed.), Human reproduction and sexual behavior. Philadelphia: Lea & Febiger 1964.Google Scholar
  275. Lombardo, M. E., C. McMorris, and P. B. Hudson: The isolation of steroidal substances from human adrenal vein blood. Endocrinology 65, 426–432 (1959).CrossRefGoogle Scholar
  276. Lucas, W. M., W. F. Whitmore, Jr., and C. D. West: Identification of testosterone in human spermatic vein blood. J. clin. Endocr. 17, 465–472 (1957).PubMedCrossRefGoogle Scholar
  277. Luetscher, J. A., Jr., and R. H. Curtis: Relationship of aldosterone in urine to sodium balance and to some other endocrine functions. J. clin. Invest. 34, 951 (1955).Google Scholar
  278. Lukens, F. D. W., and H. D. Palmer: Adrenal cortical virilism. Endocrinology 26, 941–945 (1940).CrossRefGoogle Scholar
  279. Lyon, M. F.: Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature (Lond.) 190, 372–373 (1961).CrossRefGoogle Scholar
  280. — Sex chromatin and gene action in the mammalian X-chromosome. Amer. J. hum. Genet. 14, 135–148 (1962).PubMedGoogle Scholar
  281. Marie, J.: Hyperplasie congenitale des surrénales ne comportant pas de sinus urogenital et s’accompagnant de développement prémature des seins. Sem. Hôp. Paris 33, 1594–1598 P (1957).PubMedGoogle Scholar
  282. Mason, H. L.: Metabolites of 11-dehydrocorticosterone: pregnane-3(α),20-diol-11-one. J. Biol. Chem. 172, 783–787 (1948).PubMedGoogle Scholar
  283. —, and E. J. Kepler: Isolation of steroids from the urine of patients with adrenal cortical tumors and adrenal cortical hyperplasia: A new 17-ketosteroid, androstane-3(α),11-diol-17-one. J. Biol. Chem. 161, 235–257 (1945).PubMedGoogle Scholar
  284. Masuda, M.: Urinary ketosteroid excretion patterns in congenital adrenal hyperplasia. J. clin. Endocr. 17, 1181–1190 (1957).PubMedCrossRefGoogle Scholar
  285. Mattox, V. R., A. B. Hayles, R. M. Salassa, and F. R. Dion: Urinary steroid patterns and loss of salt in congenital adrenal hyperplasia. J. clin. Endocr. 24, 517–527 (1964).PubMedCrossRefGoogle Scholar
  286. Melllman, W. J., A. M. Bongiovanni, and J. W. Hope: The diagnostic usefulness of skeletal maturation in an endocrine clinic. Pediatrics 23, 530–544 (1959).Google Scholar
  287. Migeon, C. J.: Fractionation by countercurrent distribution of urinary estrogens in normal individuals and in patients with hyperadrenocorticism. J. clin. Endocr. 13, 674–687 (1953).PubMedCrossRefGoogle Scholar
  288. — Adrenocortical function and plasma 17-ketosteroids in man. Ciba Foundation Colloquia on Endocrinology, vol. VIII, The human adrenal cortex, p. 141–156 (1955).Google Scholar
  289. — Androgens in human plasma, In: H. N. Antoniades (ed.), Hormones in human plasma, p. 305. Boston: Little, Brown & Co. 1960.Google Scholar
  290. —, and L. I. Gardner: Urinary estrogens (measured fluorometrically and biologically) in hyperadrenocorticism: influence of cortisone, compound F, compound B, and ACTH. J. clin. Endocr. 12, 1513–1531 (1952).PubMedCrossRefGoogle Scholar
  291. —, and J. E. Plager: Identification and isolation of dehydroisoandrosterone from peripheral human plasma. J. Biol. Chem. 209, 767–772 (1954).PubMedGoogle Scholar
  292. Miller, E. C., Jr., and H. L. Murray: Congenital adrenocortical hyperplasia: case previously reported as “Bilateral interstitial cell tumor of the testicle”. J. clin. Endocr. 22, 655–657 (1962).PubMedCrossRefGoogle Scholar
  293. Miyake, T., H. Imura, and H. Muranaka: Plasma adrenocorticotropic hormone in normal subjects and patients with endocrine disorders; with observations on the effect of adrenal steroids and adrenal 11β-hydroxylase inhibitors. Endocr. jap. 9, 223–233 (1962).CrossRefGoogle Scholar
  294. Moncrieff, A.: Non-adrenal female pseudohermaphroditism associated with hormone administration in pregnancy. Lancet 1958II, 267–268.CrossRefGoogle Scholar
  295. Mosier, H. D., and W. E. Goodwin: Feminizing adrenal adenoma in a 7-year-old boy. Pediatrics 27, 1016–1021 (1961).PubMedGoogle Scholar
  296. Munson, P. L., T. F. Gallagher, and F. C. Koch: Isolation of dehydroisoandrosterone sulfate from normal male urine. J. Biol. Chem. 152, 67–77 (1944).Google Scholar
  297. Nabarro, J. D. N., A. Moxham, and G. Walker: Stimulation and suppression of the adrenal cortex in Cushing’s syndrome. J. clin. Endocr. 18, 586–599 (1958).PubMedCrossRefGoogle Scholar
  298. Narbutt, B.: Modifications des éliminations stéroïdiques sous l’influence du panthothenate de calcium et de la L-cystine dans un cas d’hyperplasie congénitale des surrénales. Presse méd. 68, 955–957 (1960).PubMedGoogle Scholar
  299. Naujoks, H.: Adrenogenitales Syndrom bei eineiigen Zwillingen. Geburtsh. u. Frauenheilk. 21, 685–694 (1961).Google Scholar
  300. Neher, R., P. Desaulles, E. Vischer, P. Weiland u. A. Wettstein: Isolierung, Konstitution und Synthese eines neuen Steriodes aus Nebennieren. Helv. chim. Acta 41, 1667–1692 (1958).CrossRefGoogle Scholar
  301. —, C. Meystre u. A. Wettstein: Neue 16α-hydroxysteroide aus menschlichem Urin und aus Schweine-Nebennieren. Isolierung, Konstitution, Synthesen. Helv. chim. Acta 42, 132–152 (1959).CrossRefGoogle Scholar
  302. Nellhaus, G.: Artificially induced female pseudohermaphroditism. New Engl. J. Med. 258, 935–938 (1958).PubMedCrossRefGoogle Scholar
  303. Nelson, D. H.: Corticotrophin in human plasma, p.626. In: E. B. Astwood (ed.), Clinical endocrinology. New York: Grune & Stratton 1960.Google Scholar
  304. — J. W. Meakin, and G. W. Thorn: ACTH-producing pituitary tumors following adrenalectomy for Cushing’s syndrome. Ann. intern. Med. 52, 560–569 (1960).PubMedGoogle Scholar
  305. Ney, K. H., and R. Ammon: The occurrence of aryl and steroid sulfatases. Hoppe-Seyler’s Z. physiol. Chem. 315, 145–156 (1959).PubMedCrossRefGoogle Scholar
  306. Nilsson, L. R., and L. Söderhjeim: Female non-adrenal pseudohermaphroditism. Acta paediat. (Uppsala) 47, 603–610 (1958).CrossRefGoogle Scholar
  307. Nugent, C. A., K. Eik-Nes, H. S. Kent, L. T. Samuels, and F. H. Tyler: A possible explanation for Cushing’s syndrome associated with adrenal hyperplasia. J. clin. Endocr. 20, 1259–1268 (1960).PubMedCrossRefGoogle Scholar
  308. O’Donnell, V. J., J. Birnie, and E. MacArthur: The biogenesis and transformations of steroid hormones by the adrenal cortex in the adrenogenital syndrome. In: A. R. Currie, T. Symington and J. K. Grant (eds.), The human adrenal cortex, p. 393–406. Baltimore: Williams & Wilkins Co. 1962.Google Scholar
  309. Oertel, G. W., and K. Eik-Nes: In vivo conversion of 5-pregnene-3β-ol–20-one to plasma dehydroepiandrosterone (DHEA) and androsterone in the dog. Fed. Proc. 17, 400 (1958).Google Scholar
  310. — — Plasma levels of dehydroepiandrosterone in the dog. Endocrinology 65, 766–776 (1959a).PubMedCrossRefGoogle Scholar
  311. — — Isolation and identification of testosterone in systemic blood from normal human male adults. Proc. Soc. exp. Biol. (N. Y.) 102, 553–556 (1959b).Google Scholar
  312. —, u. E. Kaiser: Bestimmung von Testosteron im peripheren Plasma junger Männer. Klin. Wschr. 39, 1146 (1961).PubMedCrossRefGoogle Scholar
  313. Okada, M., D. K. Fukushima, and T. F. Gallagher: Isolation and characterization of 3β-hydroxy-Δ 5 steroids in adrenal carcinoma. J. Biol. Chem. 234, 1688–1692 (1959).PubMedGoogle Scholar
  314. Pansegrau, D. G., and R. E. Peterson: Improved staining of sex chromatin. Amer. J. clin. Path. 41, 266–272 (1964).Google Scholar
  315. Papadatos, C., and R. Klein: Nonadrenal female pseudohermaphrodism. J. Pediat. 45, 662–667 (1954).PubMedCrossRefGoogle Scholar
  316. Paris, J., M. Upson, Jr., R. G. Sprague, R. M. Salassa, and A. Albert: Corticotrophic activity of human blood. J. clin. Endocr. 14, 597–607 (1954).PubMedCrossRefGoogle Scholar
  317. Park, W. W.: The occurrence of sex chromatin in early human and macaque embryos. J. Anat. (Lond.) 91, 369–373 (1957).Google Scholar
  318. Perkoff, G. T., A. A. Sandberg, D. H. Nelson, and F. H. Tyler: Clinical usefulness of determination of circulating 17-hydroxycorticosteroid levels. Arch. intern. Med. 93, 1–8 (1954).CrossRefGoogle Scholar
  319. Perloff, W. H., B. J. Channick, B. Suplick, and E. R. Carrington: Clinical management of idiopathic hirsutism (adrenal virilism). J. Amer. med. Ass. 167, 2041–2047 (1958).CrossRefGoogle Scholar
  320. — K. B. Conger, and L. M. Levy: Female pseudohermaphrodism: a description of 2 unusual cases. J. clin. Endocr. 13, 783–790 (1953).PubMedCrossRefGoogle Scholar
  321. —, and H. E. Hadd: The adrenogenital syndrome “virilizing type” in an adult male: a case report. Amer. J. med. Sci. 234, 441–443 (1957).PubMedCrossRefGoogle Scholar
  322. Phillips, J.: Four cases of spurious hermaphroditism in one family. Trans. obstet. Soc. Lond. 28, 158–168 (1886).Google Scholar
  323. Polley, H. F., and H. L. Mason: Rheumatoid arthritis. Effects of certain steroids other than cortisone and of some adrenal cortex extracts. J. Amer. med. Ass. 143, 1474–1482 (1950).CrossRefGoogle Scholar
  324. Pond, M. H.: 17-Ketosteroid fractionation studies by a micro-chromatographic technique in endocrine disorders. J. Endocr. 10, 202–211 (1954).PubMedCrossRefGoogle Scholar
  325. Prader, A.: Cortisondauerbehandlung des kongenitalen adrenogenitalen Syndroms. Helv. paediat. Acta 8, 386–423 (1953).PubMedGoogle Scholar
  326. Prader, A.: Der Genitalbefund beirn Pseudohermaphroditismus feminus des kongenitalen adrenogenitalen Syndroms. Morphologie, Häufigkeit, Entwicklung und Vererbung der verschiedenen Genitalformen. Helv. paediat. Acta 9, 231–248 (1954).PubMedGoogle Scholar
  327. — Die Häufigkeit des kongenitalen adrenogenitalen Syndroms. Helv. paediat. Acta 13, 426–431 (1958).PubMedGoogle Scholar
  328. —, u. H. P. Gurtner: Das Syndrom des Pseudohermaphroditismus masculinus bei kongenitaler Nebennierenrinden-hyperplasie ohne Androgenüberproduktion, (adrenales Pseudohermaphroditismus masculinis). Helv. paediat. Acta 10, 397–412 (1955).PubMedGoogle Scholar
  329. —, u. R. E. Siebenmann: Nebenniereninsuffizienz bei kongenitaler Lipoidhyperplasie der Nebennieren. Helv. paediat. Acta 12, 569–595 (1957).PubMedGoogle Scholar
  330. — — Congenital adrenal insufficiency with lipide hyperplasia of the adrenals and female genitalia in boys. Symposium on Nuclear Sex, London, 1957, p. 62–65 (published 1958).Google Scholar
  331. — A., A. Spahr u. K. Neher: Erhöhte Aldosteronausscheidung beim kongenitalen adrenogenitalen Syndrom: ein Beitrag zur Pathogenese des Syndrom: Schweiz. med. Wschr. 85, 1085–1088 (1955).PubMedGoogle Scholar
  332. Prunty, F. T. G., R. V. Brooks, and D. Mattingly: Development of hirsutism after puberty. Brit. med. J. 1958II, 1554–1557.CrossRefGoogle Scholar
  333. Raiti, S., and G. H. Newns: Congenital adrenal hyperplasia. Arch. Dis. Childh. 39, 324–333 (1964).PubMedCrossRefGoogle Scholar
  334. Rapaport, E., M.B. Goldberg, G. S. Gordan, and F. Hinman, Jr.: Mortality in surgically treated adrenocortical tumors. II. Review of cases reported for 20 year period 1930–1949, inclusive. Postgrad. Med. 11, 325–353 (1952).PubMedGoogle Scholar
  335. Reifenstein, E. C., Jr.: 17-Alpha-hydroxyprogesterone and the virilism of the adrenogenital syndrome associated with congenital adrenocortical hyperplasia — a review. J. clin. Endocr. 16, 1262–1275 (1956).PubMedCrossRefGoogle Scholar
  336. Reilly, W. A., F. Hinman, D. E. Pickering, and J. T. Crane: Phallic urethra in female pseudohermaphroditism. Amer. J. Dis. Child. 95, 9–17 (1958).Google Scholar
  337. Revol, A., R. Mallein et P. Guinet: Étude biochimique d’une tumour surrénalienne virilisante. Ann. Biol. clin. 18, 565–570 (1960).Google Scholar
  338. Reynolds, J. W., and R. A. Ulstrom: 6β-Hydroxy compound S: report of its isolation from a case of the hypertensive form of congenital adrenal hyperplasia. Biochim. biophys. Acta (Amst.) 57, 606–608 (1962).CrossRefGoogle Scholar
  339. — — Studies of cortisol metabolism in a case of the hypertensive form of congenital adrenal hyperplasia: demonstration of the absence of 11β-dehydroxylation. J. clin. Endocr. 23, 191–196 (1963).PubMedCrossRefGoogle Scholar
  340. Riondel, A., J. F. Tait, M. Gut, S. A. S. Tait, E. Joaohim, and B. Little: Estimation of testosterone in human peripheral blood using S35-thiosemicarbazide. J. clin. Endocr. 23, 620–628 (1963).PubMedCrossRefGoogle Scholar
  341. Roberts, K. D., L. Bandi, H. I. Calvin, W. D. Druoker, and S. Lieberman: Evidence that cholesterol sulfate is a precursor of steroid hormones. J. Amer. chem. Soc. 86, 958–959 (1964).CrossRefGoogle Scholar
  342. — R. L. van de Wiele, and S. Lieberman: 17α-Hydroxypregnenolone as a precursor of urinary steroids in a patient with a virilizing adenoma of the adrenal. J. clin. Endocr. 21, 1522–1533 (1961a).PubMedCrossRefGoogle Scholar
  343. — — — The conversion in vivo of dehydroisoandrosterone sulfate to androsterone and etiocholanolone glucuronidates. J. biol. Chem. 236, 2213–2215 (1961 b).PubMedGoogle Scholar
  344. Robinson, G. C., J. R. Miller, and H. W. McIntosh: Occurrence of congenital adrenal hyperplasia in half sisters. Pediatrics 28, 946–949 (1961).PubMedGoogle Scholar
  345. Rose, E. K., H. T. Enterline, J. E. Rhoads, and E. Rose: Adrenal cortical hyperfunction in childhood. Report of a case with adrenocortical hyperplasia and testicular adrenal rests. Pediatrics 9, 475–484 (1952).PubMedGoogle Scholar
  346. Rosemberg, E., F. X. Dufault, Jr., E. Bloch, E. Budnitz, P. Butler, and J. Brem: The effects of progressive reduction of sodium intake on adrenal steroid excretion and electrolyte balance in a case of congenital adrenal hyperplasia of the salt losing type. J. clin. Endocr. 20, 214–228 (1960).PubMedCrossRefGoogle Scholar
  347. Ross, E. J.: Urinary excretion of cortisol in Cushing’s syndrome: effect of corticotropin. J. clin. Endocr. 20, 1360–1365 (1960).PubMedCrossRefGoogle Scholar
  348. Rosselet, J. P., J. W. Jailer, and S. Lieberman: The metabolism of 21-deoxysteroids. J. Biol. Chem. 225, 977–994 (1957).PubMedGoogle Scholar
  349. — L. Overland, J. W. Jailer u. S. Lieberman: Die Isolierung von 3α,17α,21-Trioxypregnanon-(20) (THS) aus menschlichem Harn. Helv. chim. Acta 37, 1933–1941 (1954).CrossRefGoogle Scholar
  350. Rubin, B. L., R. I. Dorfman, and A. Dorfman: Adrenocorticotropic hormone (ACTH) in urine. J. clin. Endocr. 14, 154–160 (1954a).PubMedCrossRefGoogle Scholar
  351. — —, and G. Pincus: Quantitative determination of seven urinary 17-ketosteroids. Recent Progr. Hormone Res. 9, 213–234 (1954b).Google Scholar
  352. Salhanick, H. A., and D. L. Berliner: Isolation of steroids from a feminizing adrenal carcinoma. J. Biol. Chem. 227, 583–590 (1957).PubMedGoogle Scholar
  353. Sandison, A. T.: A form of lipoidosis of the adrenal cortex in an infant. Arch. Dis. Child. 30, 538–541 (1955).PubMedCrossRefGoogle Scholar
  354. Savard, K., R. I. Dorfman, B. Baggett, L. L. Fielding, L. L. Engel, H. T. McPherson, L. M. Lister, D. S. Johnson, E. C. Hamblen, and F. L. Engel: Clinical, morphological, and biochemical studies of a virilizing tumor in the testis. J. clin. Invest. 39, 534–553 (1960).PubMedCrossRefGoogle Scholar
  355. Schenker, S., H. Wilson, and A. Spickard: Periodic fever associated with increased plasma unconjugated etiocholanolone and granulomatous liver disease: case report and studies in etiocholanolone and cortisol conjugation. J. clin. Endocr. 23, 95–106 (1963).PubMedCrossRefGoogle Scholar
  356. Schoen, E. J., V. di Raimondo, and O. V. Dominguez: Bilateral testicular tumors complicating congenital adrenocortical hyperplasia. J. clin. Endocr. 21, 518–532 (1961).PubMedCrossRefGoogle Scholar
  357. Searle, W. N., M. Haines, and J. K. Barer: Virilizing tumours of the ovary, with report of a case associated with pregnancy. J. Obstet. Gynaec. Brit. Emp. 55, 135–141 (1948).PubMedCrossRefGoogle Scholar
  358. Segaloff, A.,C. Y. Bowers, D. L. Gordon, J. V. Schlosser, and P. J. Murison: Hormonal therapy in cancer of the breast. XII. The effect of etiocholanolone therapy on clinical course and hormonal excretion. Cancer (Philad.) 10, 1116–1118 (1957).CrossRefGoogle Scholar
  359. — D. Gordon, and B. N. Horwitt: Differential diagnosis of adrenal lesions by the use of the intravenous administration of hydrocortisone. J. Lab. clin. Med. 45, 219–227 (1955).PubMedGoogle Scholar
  360. Segre, E. J., J. Lobotsky, and C. W. Lloyd: Plasma testosterone in normal and virilized women. The Endocrine Society, Program of the 46th Meeting. June 18–20, 1964. San Francisco, California. Abstract 90.Google Scholar
  361. Serrano, P. A., I. Dyrenfurth, and E. H. Venning: Steroid metabolism in a case of benign adrenocortical tumor. J. clin. Endocr. 22, 240–244 (1962).PubMedCrossRefGoogle Scholar
  362. Sharma, D. C., E. Forcidelli, and R. I. Dorfman: Inhibition of enzymatic steroid 11β-hydroxylation by androgens. J. Biol. Chem. 238, 572–575 (1963).Google Scholar
  363. Shephard T. H. II., and S. W. Clausen: Case of adrenogenital syndrome with hypertension treated with cortisone. Pediatrics 8, 805–813 (1951).Google Scholar
  364. Shorr, E., and A. C. Carter: A study of biological activity and the magnitude of endogenous androgen production in a case of andrenogenital syndrome. In: E. C. Reifenstein Jr. (ed.), Conference on Metabolic Aspects of Convalescence, Trans. 16th meeting. New York: Josiah Macy, Jr. Foundation 1947.Google Scholar
  365. Short, R. V.: Adrenal steroid production by the placenta, foetus and new-born. Brit. med. Bull. 18, 106–109 (1962).PubMedGoogle Scholar
  366. Simpson, S. L.: Pituitary-adrenal hyperfunction. Proc. roy. Soc. Med. 46, 39–44 (1953).PubMedGoogle Scholar
  367. Slaunwidte, W. R., Jr., and K. W. Buchwald: Urinary 17-ketosteroids and estrogens in a case of feminizing adrenal tumor. J. clin. Endocr. 20, 786–791 (1960).CrossRefGoogle Scholar
  368. Smith, D. W., P. M. Marden, M. J. McDonald, and M. Speckhard: Lower incidence of sex chromatin in buccal smears of newborn females. Pediatrics 30, 707–711 (1962).Google Scholar
  369. Snaith, A. H.: Feminizing adrenal tumor in a girl. J. clin. Endocr. 18, 318–322 (1958).PubMedCrossRefGoogle Scholar
  370. Sobel, E. H., R. C. Sniffen, and N. B. Talbot: The testes. V. Use of testicular biopsies in the differential diagnosis of precocious puberty. Pediatrics 8, 701–716 (1951).PubMedGoogle Scholar
  371. Soffer, L. J., J. L. Gabrilove, and J. W. Jailer: Metabolic studies with adrenocorticotropin in Cushing’s syndrome and in virilism. J. clin. Endocr. 10, 594–602 (1950).PubMedCrossRefGoogle Scholar
  372. — J. Geller, and J. L. Gabrilove: Response of the plasma 17-hydroxycorticosteroid level to gel-ACTH in tumorous and non-tumorous Cushing’s syndrome. J. clin. Endocr. 17, 878–883 (1957).PubMedCrossRefGoogle Scholar
  373. Sohval, A. R.: Recent progress in human chromosome analysis and its relation to the sex chromatin. Amer. J. Med. 31, 397–441 (1961).CrossRefGoogle Scholar
  374. — Chromosomes and sex chromatin in normal and anomalous sexual development. Physiol. Rev. 43, 306–356 (1963).PubMedGoogle Scholar
  375. —, and W. Casselman: Alteration in size of nuclear sex-chromatin mass (Barr Body) induced by antibiotics. Lancet 1961II, 1386–1388.CrossRefGoogle Scholar
  376. Solomon, S., A. C. Carter, and S. Lieberman: The conversion in vivo of 17α-hydroxypregnenolone to dehydroisoandrosterone and other 17-ketosteroids. J. Biol. Chem. 235 351–355 (1960).PubMedGoogle Scholar
  377. — J. T. Lanman, J. Lind, and S. Lieberman: Biosynthesis of Δ 4-androstenedione and 17α-hydroxyprogesterone from progesterone by surviving human fetal adrenals. J. Biol. Chem. 233, 1084–1088 (1958).PubMedGoogle Scholar
  378. Sorcini, G., F. Sciarra, G. Concolino, and M. Capone: Blood testosterone levels in patients with hirsutism. Folia endocr. (Pisa) 15, 696–698 (1962).Google Scholar
  379. Southren, A. L., S. Weisenfeld, A. Laufer, and M. G. Goldner: Effect of o,p′DDD in a patient with Cushing’s syndrome. J. clin. Endocr. 21, 201–208 (1961).CrossRefGoogle Scholar
  380. Spaulding, M. H.: The development of the external genitalia in the human embryo. Contr. Embryol. Carneg. Instn 13, 67–88 (1921).Google Scholar
  381. Stanbury, J. B., J. B. Wyngaarden, and D. S. Fredrickson: Inherited variation and metabolic abnormality. In: J. B. Stanbury, J. B. Wyngaarden and D. S. Fredrickson (eds.). The metabolic basis of inherited disease, p.3–19. New York: McGraw-Hill Book Co. 1960.Google Scholar
  382. Staubitz, W. J., O. J. Oberkircher, M. H. Lent, G. W. Bissell, and W. E. Farnsworth: Feminization in an adult male with adrenal cortical carcinoma. N. Y. St. J. Med. 54, 2565–2572 (1954).Google Scholar
  383. Sweat, M. L.: Adrenocorticosteroids in peripheral and adrenal venous blood of man. J. clin. Endocr. 15, 1043–1056 (1955).PubMedCrossRefGoogle Scholar
  384. Sydnor, K. L., V. C. Kelley, R. B. Raile, R. S. Ely, and G. Sayers: Blood adrenocorticotrophin in children with congenital adrenal hyperplasia” Proc. Soc. exp. Biol. (N.Y.) 82, 695–697 (1953).Google Scholar
  385. Taylor, A. I.: Sex chromatin in the new born. Lancet 1963I, 912–914.CrossRefGoogle Scholar
  386. Thorn, G. W., A. E. Renold, A. Goldfien, D. H. Nelson, W. J. Reddy, and R. Hertz: Inhibition of corticosteroid secretion by amphenone in a patient with adrenocortical carcinoma. New Engl. J. Med. 254, 547–551 (1956).PubMedCrossRefGoogle Scholar
  387. Tilp: Hochgradige Verfettung der Nebennieren eines Säuglings. Verh. dtsch. path. Ges. 16, 305–307 (1913).Google Scholar
  388. Tomkins, G. M., and J. S. McGuire, Jr.: The adrenogenital syndrome. In: J. B. Stanbury, J. B. Wyngaarden and D. S. Fredrickson (eds.), The metabolic basis of inherited disease, p. 637–676. New York: McGraw-Hill Book Co. 1960.Google Scholar
  389. Touchstone, J. C., H. Bulaschenko, E. M. Richardson, and F. C. Dohan: The excretion of pregnane-3α,17α,21-triol-20-one (tetrahydro S) in normal and pathologic urine. J. clin. Endocr. 17, 250–255 (1957).PubMedCrossRefGoogle Scholar
  390. — J. C., E. M. Richardson, H. Bulaschenko, I. Landolt, and F. C. Dohan: Isolation of pregnane-3-alpha, 17-alpha, 21-triol-20-one (tetrahydro Compound S) from the urine of a woman with metastatic adrenocortical carcinoma. J. clin. Endocr. 14, 676–678 (1954).PubMedCrossRefGoogle Scholar
  391. Treves, N.: Gynecomastia: the origin of mammary swelling in the male: an analysis of 406 patients with breast hypertrophy, 525 with testicular tumors and 13 with adrenal neoplasms. Cancer (Philad.) 11, 1083–1102 (1958).CrossRefGoogle Scholar
  392. Tuttle, L. L. D., and W. B. Gordon: Functioning tumors of the adrenal cortex. Amer. Surg. 23, 326–335 (1957).Google Scholar
  393. Vance, V. K., W. J. Reddy, D. H. Nelson, and G. W. Thorn: Adrenocorticotrophic hormone in human plasma. J. clin. Invest. 41, 20–28 (1962).PubMedCrossRefGoogle Scholar
  394. Vande Wiele, R., N. P. Christy, S. Lieberman, and J. W. Jailer: Cushing’s syndrome. IV. Urinary 17-ketosteroids in patients with adrenal cortical tumors. Proc. Soc. exp. Biol. (N. Y.) 99, 520–522 (1958).Google Scholar
  395. Vanderkerckhove, D.: À propos de l’administration de méthylandrostènediol pendant la grossesse. Ann. Endocr. (Paris) 15, 513–516 (1954).Google Scholar
  396. Vant, J. R., and R. H. Horner: Adrenogenital syndrome: absence of the vagina with pregnancy and successful delivery. Amer. J. Obstet. Gynec. 85, 355–358 (1963).PubMedGoogle Scholar
  397. Verdon, T. A., Jr., J. BRuton, R. H. Herman, and W. R. Beisel: Clinical and chemical response of functioning adrenal cortical carcinoma to ortho, pará-DDD. Metabolism 11, 226–234 (1962).PubMedGoogle Scholar
  398. Villee, D. B., L. L. Engel, J. M. Loring, and C. A. Villee: Steroid hydroxylation in human fetal adrenals: formation of 16α-hydroxyprogesterone, 17-hydroxyprogesterone and deoxycorticosterone. Endocrinology 69, 354–372 (1961).PubMedCrossRefGoogle Scholar
  399. — —, and C. A. Villee: Steroid hydroxylation in human fetal adrenals. Endocrinology 65, 465–474 (1959).PubMedCrossRefGoogle Scholar
  400. Wallace, E. Z., N. P. Christy, and J. W. Jailer: Clinical application of the simplified Silber-Porter method for determining plasma 17-hydroxycorticosteroids. J. clin. Endocr. 15, 1073–1088 (1955).PubMedCrossRefGoogle Scholar
  401. —, and S. Lieberman: Biosynthesis of dehydroisoandrosterone sulfate by human adrenocortical tissue. J. clin. Endocr. 23, 90–94 (1963).PubMedCrossRefGoogle Scholar
  402. Wallach, S., H. Brown, E. Englert, Jr., and K. Eik-Nes: Adrenocortical carcinoma with gynecomastia: a case report and review of the literature. J. clin. Endocr. 17, 945–958 (1957).PubMedCrossRefGoogle Scholar
  403. Werthemann, A.: Intersexualität bei Säuglingen mit mißgebildeter Nebennierenrindenhyperplasie. Schweiz. med. Wschr. 16, 218–225 (1935).Google Scholar
  404. — Über familiäres Vorkommen von Intersexualität und Nebennierenhyperplasie. Schweiz. med. Wschr. 22, 1335–1340 (1941).Google Scholar
  405. West, C. D., B. Damast, and O. H. Pearson: Urinary estrogen excretion in Cushing’s syndrome. J. clin. Endocr. 18, 15–27 (1958).PubMedCrossRefGoogle Scholar
  406. — V. P. Hollander, T. H. Kritchevsky, and K. Dobriner: The isolation and identification of testosterone, Δ 4-androstenedione-3,17, and 7 -ketocholesterol from spermatic vein blood. J. clin. Endocr. 12, 915–916 (1962).Google Scholar
  407. — L. F. Kumagai, E. L. simons, O. V. Domingues, and D. L. Berliner: Adrenocortical carcinoma with feminization and hypertension associated with a defect in 11β-hydroxylation. J. clin. Endocr. 24, 567–579 (1964).PubMedCrossRefGoogle Scholar
  408. White, F. P., and L. E. Sutton: Adrenogenital syndrome with associated episodes of hypoglycemia. J. clin. Endocr. 11, 1395–1402 (1951).PubMedCrossRefGoogle Scholar
  409. Wieland, R. G., R. P. Levy, D. Katz, and H. Hirschmann: Evidence for secretion of 3β-hydroxyandrost-5-en-17-one sulfate by measurement in normal human adrenal venous blood. Biochim. biophys. Acta (Amst.) 78, 566–568 (1963).CrossRefGoogle Scholar
  410. Wilkins, L.: A feminizing adrenal tumor causing gynecomastia in a boy of five years contrasted with a virilizing tumor in a five year old girl. J. clin. Endocr. 8, 111–132 (1948).PubMedCrossRefGoogle Scholar
  411. — The diagnosis and treatment of endocrine disorders in childhood and adolescence. Springfield (Ill.); Ch. C. Thomas 1950.Google Scholar
  412. — The diagnosis and treatment of endocrine disorders in childhood and adolescence, ed. 2. Springfield (Ill.): Ch. C. Thomas 1957.Google Scholar
  413. — Masculinization of female fetus due to use of orally given progestins. J. Amer. med. Ass. 172, 1028–1032 (1960).CrossRefGoogle Scholar
  414. — Adrenal disorders. II. Congenital virilizing adrenal hyperplasia. Arch. Dis. Childh. 37, 231–241 (1962).PubMedCrossRefGoogle Scholar
  415. —, and J. Cara: Further studies on the treatment of congenital adrenal hyperplasia with cortisone. V. Effects of cortisone therapy on testicular development. J. clin. Endocr. 14, 287–296 (1954).PubMedCrossRefGoogle Scholar
  416. — J. F. Crigler, Jr., S. H. Silverman, L. I. Gardner, and C. J. Migeon: II. The effects of cortisone on sexual and somatic development with an hypothesis concerning the mechanism of feminization. J. clin. Endocr. 12, 277–295 (1952b).PubMedCrossRefGoogle Scholar
  417. — — — — — III. The control of hypertension with cortisone, with a discussion of varia-tions in the type of congenital adrenal hyperplasia and report of a case with probable defect of carbodydrate-regulating hormones. J. clin. Endocr. 12, 1015–1030 (1952c).PubMedCrossRefGoogle Scholar
  418. — W. Fleischmann, and J. E. Howard: Macrogenitosomia precox associated with hyperplasia of androgenic tissue of the adrenal and death from cortico-adrenal insufficiency: case report. Endocrinology 26, 385–395 (1940).CrossRefGoogle Scholar
  419. — L. I. Gardner, J. F. Crigler, Jr., S. H. Silverman, and C. J. Migeon: Further studies on the treatment of congenital adrenal hyperplasia with cortisone. I. Comparison of oral and intramuscular administration of cortisone, with a note on the suppressive action of compounds F and B on the adrenal. J. clin. Endocr. 12, 257–276 (l952a).CrossRefGoogle Scholar
  420. — M. Grumbach, J. J. van WyK, T. H. Shepard, and C. Papadatos: Hermaphroditism: Classification, diagnosis, selection of sex and treatment. Pediatrics 16, 287–302 (1955).PubMedGoogle Scholar
  421. —, and H. W. Jones, Jr.: Partial masculinization of the female fetus by the administration of oral and intramuscular progestins during gestation. Pediatrics 21, 513 (1958).Google Scholar
  422. — — G. H. Holman, and R. S. Stempfel, Jr.: Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphrodism. J. clin. Endocr. 18, 559–585 (1958).PubMedCrossRefGoogle Scholar
  423. — R. A. Lewis, R. Klein, L. I. Gardner, J. F. Crigler, Jr., E. Rosemberg, and C. J. Migeon: Treatment of congenital adrenal hyperplasia with cortisone. J. clin. Endocr. 11, 1–25 (1951).PubMedCrossRefGoogle Scholar
  424. — — —, and E. Rosemberg: The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia. Bull. Johns Hopk. Hosp. 86, 249–252 (1950).Google Scholar
  425. Williams, W. C., Jr., D. Island, R. A. A. Oldfield, Jr., and G. W. Liddle: Blood corticotropin (ACTH) levels in Cushing’s disease. J. clin. Endocr. 21, 426–432 (1961).PubMedCrossRefGoogle Scholar
  426. Wilson, H., M. B. Lipsett, and D. W. Ryan: Urinary excretions of Δ 5-pregnenetriol and other 3β-hydroxy-Δ 5 steroids by subjects with and without endocrine disease. J. clin. Endocr. 21, 1304–1320 (1961).PubMedCrossRefGoogle Scholar
  427. Wilson, K. M.: Correlation of external genitalia and sex glands in the human embryo. Contr. Emhryol. Carneg. Instn 91, 23–30 (1926).Google Scholar
  428. Witschi, E.: Embryogenesis of the adrenal and the reproductive glands. Recent Progr. Hormone Res. 6, 1–27 (1951).Google Scholar
  429. — W. O. Nelson, and S. J. Segal: Genetic, developmental and hormonal aspects of gonadal dysgenesis and sex inversion in man. J. clin. Endocr. 17, 737–753 (1957).PubMedCrossRefGoogle Scholar
  430. Wolf, E. Trowbridge, L. C. Mills, B. L. Newton, L. L. D. Tuttle, R. A. Hettig, V. P. Collins, and W. B. Gordon: Adrenocortical carcinoma causing feminization in an adult male: hormonal considerations, and results of heterotransplantation of the tumor in guinea pigs. J. clin. Endocr. 18, 310–317 (1958).PubMedCrossRefGoogle Scholar
  431. Zahn, J.: Über Intersexualität und Nebennierenrindenhyperplasie. Schweiz. med. Wschr. 78, 480–487 (1948).PubMedGoogle Scholar
  432. Zander, J.: Nachweis von Progesteron und 17α-Hydroxyprogesteron in hyperplastischen Nebennieren bei adrenogenitalem Syndrom. Klin. Wschr. 38, 5–11 (1960).PubMedCrossRefGoogle Scholar
  433. —, u. H. A. Müller: Über die Methylandrostenediolbehandlung während einer Schwangerschaft. Geburtsh. u. Frauenheilk. 13, 216–222 (1953).Google Scholar
  434. Zondek, B., and M. Finkelstein: A neutral fluorogenic substance in human urine and its increased excretion in pregnancy and pseudohermaphroditism. Acta endocr. (Kbh.) 11, 297–305 (1952).Google Scholar
  435. — — Investigation on fluorogenic substances in the phenolic (oestrone) fraction of urine and its relation to the adrenal cortex. Acta med. orient. (Tel-Aviv) 12, 206–208 (1953).Google Scholar
  436. — — Quantitative estimation of 3α,17,20α-pregnanetriol-11-one in urine as an aid in the diagnosis of pseudohermaphroditic conditions. Acta endocr. (Kbh.) 17, 452–459 (1954).Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1968

Authors and Affiliations

  • Patricia Zeis Thomas

There are no affiliations available

Personalised recommendations